Document is current
Any future updates will be listed below
-
Authors
Nasr, Patrik http://orcid.org/0000-0002-2928-4188
Forsgren, Mikael http://orcid.org/0000-0003-4630-6550
Balkhed, Wile http://orcid.org/0000-0003-4223-8968
Jönsson, Cecilia http://orcid.org/0000-0003-0981-0264
Dahlström, Nils http://orcid.org/0000-0002-4111-1693
Simonsson, Christian
Cai, Shan
Cederborg, Anna http://orcid.org/0000-0001-5071-4915
Henriksson, Martin
Stjernman, Henrik
Rejler, Martin
Sjögren, Daniel
Cedersund, Gunnar
Bartholomä, Wolf
Rydén, Ingvar http://orcid.org/0000-0002-4366-7337
Lundberg, Peter http://orcid.org/0000-0001-8661-2232
Kechagias, Stergios http://orcid.org/0000-0001-7614-739X
Leinhard, Olof Dahlqvist http://orcid.org/0000-0002-6189-0807
Ekstedt, Mattias http://orcid.org/0000-0002-5590-8601
-
Funding
Funding for this research was provided by:
Linköping University
- License Information
-
More Information
Article History
Received: 24 August 2023
Accepted: 13 December 2023
First Online: 21 December 2023
Declarations
:
: All recruitment and attainment of informed consent are conducted according to nationally accepted practice and in full accordance with the World Medical Association of Helsinki 2018. Data is collected and processed in accordance with the applicable General Data Protection Regulation (EU) 2016/679 (GDPR) legislation, and in compliance with the International Conference of Harmonization – Good Clinical Practice (ICH-GCP) requirements.The ACCESS-ESLD study was approved by the Swedish Ethical Review Authority 2020–07215, 2021-02-23 with amendments 2022–02902-02 and 2022–06142-02. All subjects gave written informed consent before any study procedures were undertaken.
: NA.
: Mattias Ekstedt has received lecture fees from Mediplast and is on the advisory Board for AMRA Medical AB. Peter Lundberg is a minority owner of AMRA Medical AB. Anna Cederborg has received lecture fees from Norgine Denmark A/S. Mikael Forsgren is a shareholder and employee of AMRA Medical AB. Olof Dahlqvist Leinhard is an employee, shareholder, and board member of AMRA Medical AB. No other author has any competing interests.
